QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Evidence Expertise
Expanding our Evidence, Review & Synthesis team
We are pleased to welcome Dr. Gulchehak Kaur to Quantify Research.
Gulchehak joins our Evidence, Review and Synthesis team with a strong foundation across clinical and economic disciplines:
📓Undergraduate degree in Dentistry
📓MSc in Health Economics, Manipal Academy of Higher Education
📓Experience in evidence synthesis and systematic literature reviews
During her previous role, she contributed to the structured evaluation of scientific evidence, supporting informed healthcare decision-making.
Her experience further […]
👥 Team growth
We are pleased to welcome Sami Gabbouj to Quantify Research as Project Leader.
Sami brings more than 10 years of experience across the biomedical field, combining scientific depth with business understanding.
His approach reflects a core challenge in our field:
➡️ translating clinical evidence into access
➡️ integrating HEOR with strategic decision-making
➡️ navigating diverse stakeholder perspectives
Before joining Quantify, Sami worked across market access, research, and business administration. This enables him to connect scientific […]
Welcome Emilia!
We are pleased to welcome Emilia Larsson to Quantify Research as Senior HR Business Partner.
Emilia brings ~8 years of HR experience across international organisations in tech, medtech, healthcare, and life sciences.
Her background includes:
• BSc in HR – Lund University
• MSc in Strategic HR Management – Gothenburg School of Business, Economics & Law
• Early career in healthcare recruitment
• Recent role as HR Business […]
RWD is only the start. How is it used in regulatory evidence?
After exploring real-world data sources across the Nordic countries, we now pivot to how this data is used in regulatory evidence generation.
One important example is Post-Authorisation safety Studies (PASS).
The PASS framework is specific to the European Union regulatory system.
Other regulators, such as the FDA, generally refer to these as post-approval studies.
PASS are conducted after a medicine is approved to further identify, characterise, or quantify safety risks.
Most PASS are non-interventional, […]